| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 13 Aug 2025 | 7 Aug 2025 |
| Hemo Organic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve Intimation of Board Meeting to be held on Wednesday 13th August 2025. | ||
| Board Meeting | 27 Jun 2025 | 27 Jun 2025 |
| Outcome of Board Meeting held today i.e., Friday, 27th June, 2025 Announcement under Regulation 30 (LODR)-Change in Management | ||
| Board Meeting | 20 May 2025 | 16 May 2025 |
| Hemo Organic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to consider and approve Intimation of Board Meeting to be held on Tuesday 20th May 2025. Outcome of Board Meeting held on Tuesday, 20th May, 2025. (As Per BSE Announcement Dated on :20.05.2025) | ||
| Board Meeting | 31 Mar 2025 | 31 Mar 2025 |
| Outcome of Board Meeting held today i.e., Monday, 31st March, 2025 | ||
| Board Meeting | 6 Feb 2025 | 3 Feb 2025 |
| Hemo Organic Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2025 inter alia to consider and approve 1. The Un-Audited Financial Results of the Company for the quarter and nine month ended as on 31st December 2024 along with Limited Review Report thereon. 2. To transact other businesses as per agenda being circulated The Board of Directors (the Board) at its meeting held on 6th February, 2025 commenced at 4.00 p.m. and concluded at 4:07 p.m., has approved and taken on record interalia: 1. The Un-Audited Financial Results (Standalone) for the quarter and nine months ended 31st December, 2024 prepared in terms of Regulation 33 of the SEBI Listing Regulations together with the Limited Review Report by the Statutory Auditors. (As Per BSE Announcement Dated on: 06/02/2025) | ||
| Board Meeting | 26 Dec 2024 | 20 Dec 2024 |
| Hemo Organic Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/12/2024 inter alia to consider and approve 1. Issue of Equity shares of the Company on Rights basis. 2. To transact other businesses as per agenda being circulated. Outcome of Board Meeting held today i.e., 26th December, 2024 (As Per Bse Announcement Dated on 26.12.2024) | ||
| Board Meeting | 28 Oct 2024 | 23 Oct 2024 |
| Hemo Organic Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve a) the Un-Audited Financial Results of the Company for the quarter and half year ended as on 30th September 2024 along with Limited Review Report thereon. b) To transact other businesses as per agenda being circulated. Outcome of Board Meeting held today i.e. on Monday, 28th October,2024 (As per BSE Announcement Dated on 28/10/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.